{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-cough/management/covid-19/","result":{"pageContext":{"chapter":{"id":"350b3d29-e254-59ab-a297-4fad68eecad4","slug":"covid-19","fullItemName":"Scenario: COVID-19","depth":2,"htmlHeader":"<!-- begin field ce4fa12e-3526-469f-bd09-ab9500a0710e --><h2>Scenario: COVID-19 Management</h2><!-- end field ce4fa12e-3526-469f-bd09-ab9500a0710e -->","summary":"Covers management when considering the possibility of COVID-19.","htmlStringContent":"<!-- begin item ed4b8557-4148-4d63-9520-ab9500a070c3 --><!-- begin field 79fb87b7-150c-4d0f-a19a-acbd008698c1 --><p>From birth onwards.</p><!-- end field 79fb87b7-150c-4d0f-a19a-acbd008698c1 --><!-- end item ed4b8557-4148-4d63-9520-ab9500a070c3 -->","topic":{"id":"d321ef5c-4612-5a6b-aafc-a656ec8fb1e6","topicId":"561865b5-2a09-480f-ae63-783b229b69bf","topicName":"Palliative care - cough","slug":"palliative-care-cough","lastRevised":"Last revised in April 2020","chapters":[{"id":"bce97da8-92b8-599d-88a3-f95ee1c136d2","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ff610ad5-9e7b-56ea-8eac-bfd602137594","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8409825-4431-5ee0-9294-3c43a9596f99","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e1226b71-f64b-5a62-81df-0219b18ce529","slug":"changes","fullItemName":"Changes"},{"id":"3ad0995f-5610-51ce-bb35-457850cd484e","slug":"update","fullItemName":"Update"}]},{"id":"d7bb7e5e-514b-547f-9b69-4fb3327ec125","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"74afa2f6-d51b-5cbd-b460-b6e4d03732af","slug":"goals","fullItemName":"Goals"},{"id":"34cc375e-0ca3-5323-a1cd-021d11c018db","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a037a0d5-cb13-59dc-94c7-55040a012faf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9342453d-dbf4-55fb-b5dc-50216b89f42b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bd5feaf8-f260-59ed-9474-23ad808b0e62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00a6af51-79f3-5510-a3e6-1f4f8c942f40","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5811a833-882d-55ab-a3f5-09d1feff4254","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2bfea1d4-d4ce-5066-af76-c1bc08c5c287","slug":"purpose-mechanism-of-cough","fullItemName":"Purpose and mechanism of cough"},{"id":"e6e866d7-040b-5653-a045-a47d96b61bda","slug":"prevalence-of-cough-in-palliative-care","fullItemName":"Prevalence of cough in palliative care"},{"id":"848fec2b-a258-59bb-99e5-11ab01a40295","slug":"causes-of-cough-in-palliative-care","fullItemName":"Causes of cough in palliative care"},{"id":"b7268bf0-d5b4-5fde-9016-68778770d8ad","slug":"complications-of-cough","fullItemName":"Complications of cough"}]},{"id":"82094bd0-c604-5bbf-acb9-8de75cf96107","fullItemName":"Management","slug":"management","subChapters":[{"id":"b6ff7bf7-561f-55f0-ad57-2373c98c25a4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"59d61f62-958b-56b8-8aa4-2cfb39def0c1","slug":"known-cause-of-cough","fullItemName":"Scenario: Known cause of cough"},{"id":"7cb56d6a-7186-5fc1-9c6b-0f3af49e4b20","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"36252764-f5e9-5b31-ad0b-ba291aef89e7","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"350b3d29-e254-59ab-a297-4fad68eecad4","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"644dd5b8-ece9-502a-be3e-f0527653ac64","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bdaa86d3-a323-594c-b17f-71e8f0252c4c","slug":"nebulized-sodium-chloride","fullItemName":"Nebulized sodium chloride"},{"id":"b13d017f-af1d-5851-8c0e-967352e91bde","slug":"pholcodine-linctus-bp","fullItemName":"Pholcodine linctus BP"},{"id":"03f99c3c-08ce-5899-9fbe-4f57a0f2904f","slug":"codeine","fullItemName":"Codeine"},{"id":"60a78c3d-94b2-5e08-9e65-8bafd18725ba","slug":"morphine","fullItemName":"Morphine"},{"id":"45d8e905-93b4-585b-b370-12c26491e7e4","slug":"mucolytics","fullItemName":"Mucolytics"}]},{"id":"6c7c1d77-3b02-5361-979b-ceb31387e824","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"dd028d8e-6a48-5f6d-924a-d3970c3b0df9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"26cda216-c628-5c3c-9604-cff1e8a0a730","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f586cb3d-0420-52a2-ac78-fd155050abc9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9c55540f-e0ca-5527-8e1b-676719b74676","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"38ff8a0d-a949-566e-b696-ee543d5b835e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3f4f13e9-8e87-5cc5-b27e-0ef15bf0ac38","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b3492817-f33c-53f6-8da4-2144cd1afa9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"82094bd0-c604-5bbf-acb9-8de75cf96107","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"621ff9b7-ff27-5842-8eb9-4f914abd04fc","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 3a094adf-d213-4f14-97af-ab9500a07111 --><h3>How should my management vary when considering the possibility of COVID-19?</h3><!-- end field 3a094adf-d213-4f14-97af-ab9500a07111 -->","summary":null,"htmlStringContent":"<!-- begin item a0c68eb1-6ae8-4804-a629-ab9500a07111 --><!-- begin field 0b071117-0916-4e84-a332-ab9500a07111 --><ul><li>Be aware that older people or those with comorbidities, frailty, impaired immunity or a reduced ability to cough and clear secretions who contract COVID-19 are more likely to develop severe pneumonia. This could lead to respiratory failure and death.</li><li>If possible, encourage people with cough to avoid lying on their back as this makes coughing ineffective and so reduces clearance of secretions. </li><li>Use simple measures first, including getting people with COVID-19 related cough to take honey (for patients aged over 1 year). See Table 1 for treatments for managing cough.</li><li>For people with COVID-19 consider short-term use of codeine linctus, codeine phosphate tablets or morphine sulfate oral solution to suppress coughing if it is distressing.</li></ul><div class=\"informaltable\" style=\"color: #0e0e0e; font-size: 16px; font-variant-numeric: normal; font-variant-east-asian: normal; height: 100%; margin-bottom: 24px; overflow: auto hidden;\"><table id=\"ID0EHG\" style=\"border: 1px solid #999999; border-spacing: 0px; margin-bottom: 24px; overflow-wrap: break-word; width: 100%;\" border=\"1\" frame=\"all\"><caption style=\"padding-bottom: 5px; text-align: left;\"><strong>Table 1. </strong>Treatments for managing cough in adults aged 18 years and over</caption><thead></thead><tbody><tr><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\"><strong>Treatment</strong></p></td><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\"><strong>Dosage</strong></p></td></tr><tr><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\"><strong>Initial management:</strong> use simple non-drug measures, for example taking honey</p></td><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">A teaspoon of honey.</p></td></tr><tr><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\"><strong>First choice, only if cough is distressing:</strong> codeine linctus (15 mg/5 ml) or codeine phosphate tablets (15 mg, 30 mg)</p></td><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">15 mg to 30 mg every 4 hours as required, up to 4 doses in 24 hours.</p><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">If necessary, increase dose to a maximum of 30 mg to 60 mg 4 times a day (maximum 240 mg in 24 hours).</p></td></tr><tr><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\"><strong>Second choice, only if cough is distressing:</strong> morphine sulfate oral solution (10 mg/5 ml)</p></td><td style=\"border-color: #999999; line-height: 24px; overflow-wrap: break-word; padding: 12px; vertical-align: top;\"><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">2.5 mg to 5 mg when required every 4 hours.</p><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">Increase up to 5 mg to 10 mg every 4 hours as required.</p><p style=\"padding: 0px; margin: 0px 0px 12px 0px;\">If the patient is already taking regular morphine increase the regular dose by a third.</p></td></tr></tbody></table><ul><li>All doses are for oral administration.</li><li>Consider addiction potential of codeine linctus, codeine phosphate and morphine sulfate.</li><li>NICE advises issuing an 'acute' prescription with a limited supply. Advise the person of the risks of constipation and consider prescribing a regular stimulant laxative.</li><li>Avoid cough suppressants in people who suffer from chronic bronchitis and bronchiectasis as this can cause sputum retention.</li><li>Seek specialist advice for people aged under 18 years.</li></ul></div><!-- end field 0b071117-0916-4e84-a332-ab9500a07111 --><!-- end item a0c68eb1-6ae8-4804-a629-ab9500a07111 -->","subChapters":[{"id":"c2add5fa-9ed4-50d7-9eee-ea1f96445d73","slug":"basis-for-recommendation-bfb","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 65676224-18d8-40d9-825f-ab9500a07113 --><h4>Basis for recommendation</h4><!-- end field 65676224-18d8-40d9-825f-ab9500a07113 -->","summary":null,"htmlStringContent":"<!-- begin item bfbf4f32-c825-408e-9fbc-ab9500a07113 --><!-- begin field c5284199-a584-469a-a265-ab9500a07113 --><p>These recommendations are based on the National Institute for Health and Care Excellence (NICE) <em>COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">NICE, 2020</a>].</p><!-- end field c5284199-a584-469a-a265-ab9500a07113 --><!-- end item bfbf4f32-c825-408e-9fbc-ab9500a07113 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}